{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:03:48Z","timestamp":1780023828906,"version":"3.53.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01436-6","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T08:34:54Z","timestamp":1776587694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic [\u00b9\u2078F]F-AraG PET imaging of T Cell activation: a functional complement to cell-specific immune tracers"],"prefix":"10.1186","volume":"16","author":[{"given":"Waleed M.","family":"Almutairi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gopaulchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Bhaskara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Huang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus A.","family":"Ocana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teessa Perekattu","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Durm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseyi M.","family":"Oderinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"issue":"2","key":"1436_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2967\/jnumed.121.261976","volume":"63","author":"C Li","year":"2022","unstructured":"Li C, Han C, Duan S, Li P, Alam IS, Xiao Z. Visualizing T-Cell Responses: The T-Cell PET Imaging Toolbox. J Nucl Med. 2022;63(2):183\u20138. https:\/\/doi.org\/10.2967\/jnumed.121.261976.","journal-title":"J Nucl Med"},{"key":"1436_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2021.03.009","volume":"507","author":"G Wang","year":"2021","unstructured":"Wang G, Zhang M, Cheng M, Wang X, Li K, Chen J, et al. Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms. Cancer Lett. 2021;507:55\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2021.03.009. PubMed PMID: 33741424.","journal-title":"Cancer Lett"},{"issue":"8","key":"1436_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11912-020-00938-3","volume":"22","author":"NE Wondergem","year":"2020","unstructured":"Wondergem NE, Nauta IH, Muijlwijk T, Leemans CR, van de Ven R. The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites. Curr Oncol Rep. 2020;22(8):81. https:\/\/doi.org\/10.1007\/s11912-020-00938-3. PubMed PMID: 32602047; PubMed Central PMCID: PMC7324425.","journal-title":"Curr Oncol Rep"},{"key":"1436_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-4939","volume":"2024","author":"KM Fulton","year":"2019","unstructured":"Fulton KM, Baltat I, Twine SM. Immunoproteomics Methods and Techniques. Methods Mol Biol Clifton NJ. 2019;2024:25\u201358. https:\/\/doi.org\/10.1007\/978-1-4939. 9597-4_2 PubMed PMID: 31364041.","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"1436_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/B978-0-444-63432-0.00004-9","volume":"133","author":"KL Medina","year":"2016","unstructured":"Medina KL. Overview of the immune system. Handb Clin Neurol. 2016;133:61\u201376. https:\/\/doi.org\/10.1016\/B978-0-444-63432-0.00004-9. PubMed PMID: 27112671.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"1436_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662\u201380. https:\/\/doi.org\/10.1038\/s41568-020-0285-7.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1436_CR7","doi-asserted-by":"publisher","first-page":"189289","DOI":"10.1016\/j.bbcan.2025.189289","volume":"1880","author":"Y Liang","year":"2025","unstructured":"Liang Y, Xie M, Zang X, Zhang X, Xue X. Evaluation of ImmunoPET in the efficacy and prognosis of immunotherapy for lung cancer. Biochim Biophys Acta BBA - Rev Cancer. 2025;1880(2):189289. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189289.","journal-title":"Biochim Biophys Acta BBA - Rev Cancer"},{"issue":"1","key":"1436_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235. https:\/\/doi.org\/10.1038\/s41392-023-01471-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1436_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1773-2247(13)50002-5","volume":"23","author":"NH Kim","year":"2013","unstructured":"Kim NH, Nadithe V, Elsayed M, Merkel OM. Tracking and treating activated T cells. J Drug Deliv Sci Technol. 2013;23(1):17\u201321. https:\/\/doi.org\/10.1016\/S1773-2247(13)50002-5.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"1436_CR10","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2967\/jnumed.123.267003","volume":"65","author":"N Omidvari","year":"2024","unstructured":"Omidvari N, Levi J, Abdelhafez YG, Wang Y, Nardo L, Daly ME, et al. Total-Body Dynamic Imaging and Kinetic Modeling of [18 F]F-AraG in Healthy Individuals and a Non\u2013Small Cell Lung Cancer Patient Undergoing Anti\u2013PD-1 Immunotherapy. J Nucl Med. 2024;65(9):1481\u20138. https:\/\/doi.org\/10.2967\/jnumed.123.267003.","journal-title":"J Nucl Med"},{"issue":"11","key":"1436_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20(11):651\u201368. https:\/\/doi.org\/10.1038\/s41577-020-0306-5.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1436_CR12","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primer. 2018;4(1):18001. https:\/\/doi.org\/10.1038\/nrdp.2018.1.","journal-title":"Nat Rev Dis Primer"},{"key":"1436_CR13","doi-asserted-by":"publisher","first-page":"1084887","DOI":"10.3389\/fimmu.2023.1084887","volume":"14","author":"A Tiwari","year":"2023","unstructured":"Tiwari A, Oravecz T, Dillon LA, Italiano A, Audoly L, Fridman WH, et al. Towards a consensus definition of immune exclusion in cancer. Front Immunol. 2023;14:1084887. https:\/\/doi.org\/10.3389\/fimmu.2023.1084887.","journal-title":"Front Immunol"},{"issue":"7637","key":"1436_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I. Elements of cancer immunity and the cancer\u2013immune set point. Nature. 2017;541(7637):321\u201330. https:\/\/doi.org\/10.1038\/nature21349.","journal-title":"Nature"},{"key":"1436_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fimmu.2020.01067","volume":"11","author":"CE McCarthy","year":"2020","unstructured":"McCarthy CE, White JM, Viola NT, Gibson HM. In vivo Imaging Technologies to Monitor the Immune System. Front Immunol. 2020;11:1067. https:\/\/doi.org\/10.3389\/fimmu.2020.01067.","journal-title":"Front Immunol"},{"issue":"12","key":"1436_CR16","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/s41591-022-02084-8","volume":"28","author":"L Kist De Ruijter","year":"2022","unstructured":"Kist De Ruijter L, Van De Donk PP, Hooiveld-Noeken JS, Giesen D, Elias SG, Lub-de Hooge MN, et al. Whole-body CD8\u2009+\u2009T cell visualization before and during cancer immunotherapy: a phase 1\/2 trial. Nat Med. 2022;28(12):2601\u201310. https:\/\/doi.org\/10.1038\/s41591-022-02084-8.","journal-title":"Nat Med"},{"issue":"25","key":"1436_CR17","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.7150\/thno.37924","volume":"9","author":"M Krekorian","year":"2019","unstructured":"Krekorian M, Fruhwirth GO, Srinivas M, Figdor CG, Heskamp S, Witney TH, et al. Imaging of T-cells and their responses during anti-cancer immunotherapy. Theranostics. 2019;9(25):7924\u201347. https:\/\/doi.org\/10.7150\/thno.37924.","journal-title":"Theranostics"},{"issue":"2","key":"1436_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8\u2009+\u2009T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124(2):359\u201367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4.","journal-title":"Br J Cancer"},{"issue":"13","key":"1436_CR19","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1158\/0008-5472.CAN-19-0267","volume":"79","author":"J Levi","year":"2019","unstructured":"Levi J, Lam T, Goth SR, Yaghoubi S, Bates J, Ren G, et al. Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy. Cancer Res. 2019;79(13):3455\u201365. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0267.","journal-title":"Cancer Res"},{"key":"1436_CR20","doi-asserted-by":"publisher","first-page":"3667417","DOI":"10.1155\/2022\/3667417","volume":"2022","author":"J Levi","year":"2022","unstructured":"Levi J, Duan H, Yaghoubi S, Packiasamy J, Huynh L, Lam T, et al. Biodistribution of a Mitochondrial Metabolic Tracer, [18 F]F-AraG, in Healthy Volunteers. Mol Imaging. 2022;2022:3667417. https:\/\/doi.org\/10.1155\/2022\/3667417.","journal-title":"Mol Imaging"},{"key":"1436_CR21","doi-asserted-by":"publisher","first-page":"1428541","DOI":"10.3389\/fimmu.2024.1428541","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Du B, Wang Y, Cui Y, Wang S, Zhao Y, et al. The role of CD8 PET imaging in guiding cancer immunotherapy. Front Immunol. 2024;15:1428541. https:\/\/doi.org\/10.3389\/fimmu.2024.1428541.","journal-title":"Front Immunol"},{"issue":"5","key":"1436_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.remnie.2022.08.001","volume":"41","author":"F Mulero","year":"2022","unstructured":"Mulero F. ImmunoPET in oncology. Rev Esp Med Nucl E Imagen Mol Engl Ed. 2022;41(5):332\u20139. https:\/\/doi.org\/10.1016\/j.remnie.2022.08.001.","journal-title":"Rev Esp Med Nucl E Imagen Mol Engl Ed"},{"key":"1436_CR23","doi-asserted-by":"publisher","first-page":"1231525","DOI":"10.3389\/fmed.2023.1231525","volume":"10","author":"F Mulero","year":"2023","unstructured":"Mulero F, Editorial. ImmunoPET imaging in disease diagnosis and therapy assessment. Front Med. 2023;10:1231525. https:\/\/doi.org\/10.3389\/fmed.2023.1231525.","journal-title":"Front Med"},{"issue":"8","key":"1436_CR24","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1021\/acs.chemrev.9b00738","volume":"120","author":"W Wei","year":"2020","unstructured":"Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W. ImmunoPET: Concept, Design, and Applications. Chem Rev. 2020;120(8):3787\u2013851. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00738. PubMed PMID: 32202104; PubMed Central PMCID: PMC7265988.","journal-title":"Chem Rev"},{"issue":"7","key":"1436_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","volume":"23","author":"J Schwenck","year":"2023","unstructured":"Schwenck J, Sonanini D, Cotton JM, Rammensee HG, La Foug\u00e8re C, Zender L, et al. Advances in PET imaging of cancer. Nat Rev Cancer. 2023;23(7):474\u201390. https:\/\/doi.org\/10.1038\/s41568-023-00576-4.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1436_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.rcl.2021.05.010","volume":"59","author":"O Iyalomhe","year":"2021","unstructured":"Iyalomhe O, Farwell MD, Immune PET, Imaging. Radiol Clin North Am. 2021;59(5):875\u201386. https:\/\/doi.org\/10.1016\/j.rcl.2021.05.010.","journal-title":"Radiol Clin North Am"},{"key":"1436_CR27","doi-asserted-by":"publisher","first-page":"1644692","DOI":"10.3389\/fonc.2025.1644692","volume":"15","author":"WM Almutairi","year":"2025","unstructured":"Almutairi WM, Zheng QH, Langer M, Oderinde OM. Application of immunoPET imaging to enhance head and neck squamous cell carcinoma clinical management. Front Oncol. 2025;15:1644692. https:\/\/doi.org\/10.3389\/fonc.2025.1644692.","journal-title":"Front Oncol"},{"issue":"4","key":"1436_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2967\/jnumed.119.229781","volume":"61","author":"N Pandit-Taskar","year":"2020","unstructured":"Pandit-Taskar N, Postow MA, Hellmann MD, Harding JJ, Barker CA, O\u2019Donoghue JA, et al. First-in-Humans Imaging with89 Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting. J Nucl Med. 2020;61(4):512\u20139. https:\/\/doi.org\/10.2967\/jnumed.119.229781.","journal-title":"J Nucl Med"},{"issue":"7","key":"1436_CR29","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1158\/1078-0432.CCR-20-3243","volume":"27","author":"VL Nagle","year":"2021","unstructured":"Nagle VL, Henry KE, Hertz CAJ, Graham MS, Campos C, Parada LF, et al. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET. Clin Cancer Res. 2021;27(7):1958\u201366. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3243.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1436_CR30","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.20161950","volume":"214","author":"M Rashidian","year":"2017","unstructured":"Rashidian M, Ingram JR, Dougan M, Dongre A, Whang KA, LeGall C, et al. Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med. 2017;214(8):2243\u201355. https:\/\/doi.org\/10.1084\/jem.20161950.","journal-title":"J Exp Med"},{"issue":"5","key":"1436_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/biom11050637","volume":"11","author":"L Berland","year":"2021","unstructured":"Berland L, Kim L, Abousaway O, Mines A, Mishra S, Clark L, et al. Nanobodies Med Imaging: About Ready Prime Time? Biomolecules. 2021;11(5):637. https:\/\/doi.org\/10.3390\/biom11050637.","journal-title":"Nanobodies Med Imaging: About Ready Prime Time? Biomolecules"},{"key":"1436_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.iotech.2020.07.001","volume":"7","author":"M Rashidian","year":"2020","unstructured":"Rashidian M, Ploegh H. Nanobodies as non-invasive imaging tools. Immuno-Oncol Technol. 2020;7:2\u201314. https:\/\/doi.org\/10.1016\/j.iotech.2020.07.001.","journal-title":"Immuno-Oncol Technol"},{"issue":"16","key":"1436_CR33","doi-asserted-by":"publisher","first-page":"e161065","DOI":"10.1172\/JCI161065","volume":"132","author":"H Zhou","year":"2022","unstructured":"Zhou H, Wang Y, Xu H, Shen X, Zhang T, Zhou X, et al. Noninvasive interrogation of CD8\u2009+\u2009T cell effector function for monitoring early tumor responses to immunotherapy. J Clin Invest. 2022;132(16):e161065. https:\/\/doi.org\/10.1172\/JCI161065.","journal-title":"J Clin Invest"},{"issue":"5","key":"1436_CR34","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s11307-010-0414-x","volume":"13","author":"M Namavari","year":"2011","unstructured":"Namavari M, Chang YF, Kusler B, Yaghoubi S, Mitchell BS, Gambhir SS. Synthesis of 2\u2032-Deoxy-2\u2032-[18F]Fluoro-9-\u03b2-D-Arabinofuranosylguanine: a Novel Agent for Imaging T-Cell Activation with PET. Mol Imaging Biol. 2011;13(5):812\u20138. https:\/\/doi.org\/10.1007\/s11307-010-0414-x.","journal-title":"Mol Imaging Biol"},{"issue":"10\u201311","key":"1436_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/jlcr.3997","volume":"65","author":"AA H\u00f6gn\u00e4sbacka","year":"2022","unstructured":"H\u00f6gn\u00e4sbacka AA, Cort\u00e9s Gonz\u00e1lez MA, Halldin C, Schou M. Simplified and accessible [18 F]F-AraG synthesis procedure for preclinical PET. J Label Compd Radiopharm. 2022;65(10\u201311):288\u201391. https:\/\/doi.org\/10.1002\/jlcr.3997.","journal-title":"J Label Compd Radiopharm"},{"issue":"12","key":"1436_CR36","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/jlcr.3999","volume":"65","author":"DP Holt","year":"2022","unstructured":"Holt DP, Dannals RF. An improved radiosynthesis of [18 F]FAraG, a PET radiotracer for imaging T-cell activation. J Label Compd Radiopharm. 2022;65(12):302\u20138. https:\/\/doi.org\/10.1002\/jlcr.3999.","journal-title":"J Label Compd Radiopharm"},{"issue":"11","key":"1436_CR37","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1158\/0008-5472.CAN-16-2953","volume":"77","author":"JA Ronald","year":"2017","unstructured":"Ronald JA, Kim BS, Gowrishankar G, Namavari M, Alam IS, D\u2019Souza A, et al. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. Cancer Res. 2017;77(11):2893\u2013902. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2953.","journal-title":"Cancer Res"},{"key":"1436_CR38","doi-asserted-by":"publisher","first-page":"153601211771263","DOI":"10.1177\/1536012117712638","volume":"16","author":"BL Franc","year":"2017","unstructured":"Franc BL, Goth S, MacKenzie J, Li X, Blecha J, Lam T, et al. In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis. Mol Imaging. 2017;16:1536012117712638. https:\/\/doi.org\/10.1177\/1536012117712638.","journal-title":"Mol Imaging"},{"issue":"6","key":"1436_CR39","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2967\/jnumed.120.249078","volume":"62","author":"J Levi","year":"2021","unstructured":"Levi J, Goth S, Huynh L, Lam T, Huynh TL, Schulte B, et al. 18 F-AraG PET for CD8 Profiling of Tumors and Assessment of Immunomodulation by Chemotherapy. J Nucl Med. 2021;62(6):802\u20137. https:\/\/doi.org\/10.2967\/jnumed.120.249078.","journal-title":"J Nucl Med"},{"issue":"1","key":"1436_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2967\/jnumed.120.259325","volume":"63","author":"C Guglielmetti","year":"2022","unstructured":"Guglielmetti C, Levi J, Huynh TL, Tiret B, Blecha J, Tang R, et al. Longitudinal Imaging of T Cells and Inflammatory Demyelination in a Preclinical Model of Multiple Sclerosis Using18 F-FAraG PET and MRI. J Nucl Med. 2022;63(1):140\u20136. https:\/\/doi.org\/10.2967\/jnumed.120.259325.","journal-title":"J Nucl Med"},{"issue":"5","key":"1436_CR41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s11307-024-01932-y","volume":"26","author":"UM Shrestha","year":"2024","unstructured":"Shrestha UM, Chae HD, Fang Q, Lee RJ, Packiasamy J, Huynh L, et al. A Feasibility Study of [18F]F-AraG Positron Emission Tomography (PET) for Cardiac Imaging\u2013Myocardial Viability in Ischemia\u2013Reperfusion Injury Model. Mol Imaging Biol. 2024;26(5):869\u201378. https:\/\/doi.org\/10.1007\/s11307-024-01932-y.","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"1436_CR42","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s42003-024-06494-x","volume":"7","author":"J Levi","year":"2024","unstructured":"Levi J, Guglielmetti C, Henrich TJ, Yoon JC, Gokhale PC, Reardon DA, et al. [18F]F-AraG imaging reveals association between neuroinflammation and brown- and bone marrow adipose tissue. Commun Biol. 2024;7(1):793. https:\/\/doi.org\/10.1038\/s42003-024-06494-x.","journal-title":"Commun Biol"},{"issue":"754","key":"1436_CR43","doi-asserted-by":"publisher","first-page":"eadk3295","DOI":"10.1126\/scitranslmed.adk3295","volume":"16","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Ryder D, Flavell RR, Wang Y, Levi J, LaFranchi BH, et al. Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Sci Transl Med. 2024;16(754):eadk3295. https:\/\/doi.org\/10.1126\/scitranslmed.adk3295.","journal-title":"Sci Transl Med"},{"issue":"2","key":"1436_CR44","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00259-024-06931-3","volume":"52","author":"JE Wijngaarden","year":"2025","unstructured":"Wijngaarden JE, Slebe M, Pouw JEE, Oprea-Lager DE, Schuit RC, Dickhoff C, et al. Pharmacokinetic analysis and simplified uptake measures for tumour lesion [18F]F-AraG PET imaging in patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2025;52(2):719\u201329. https:\/\/doi.org\/10.1007\/s00259-024-06931-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1436_CR45","doi-asserted-by":"publisher","unstructured":"Levi J, Das M, Vasanawala MS, Behl D, Pomper M, Forde PM, et al. [18 F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non\u2013Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy. J Nucl Med. 2024 Dec;65(12):1869\u201375. https:\/\/doi.org\/10.2967\/jnumed.124.268253","DOI":"10.2967\/jnumed.124.268253"},{"issue":"7","key":"1436_CR46","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3390\/cancers12071868","volume":"12","author":"J Dewulf","year":"2020","unstructured":"Dewulf J, Adhikari K, Vangestel C, Wyngaert TVD, Elvas F. Development of Antibody Immuno-PET\/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders\u2014An Update. Cancers. 2020;12(7):1868. https:\/\/doi.org\/10.3390\/cancers12071868.","journal-title":"Cancers"},{"issue":"3","key":"1436_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00259-022-05998-0","volume":"50","author":"SK Sriraman","year":"2023","unstructured":"Sriraman SK, Davies CW, Gill H, Kiefer JR, Yin J, Ogasawara A, et al. Development of an 18F-labeled anti-human CD8 VHH for same-day immunoPET imaging. Eur J Nucl Med Mol Imaging. 2023;50(3):679\u201391. https:\/\/doi.org\/10.1007\/s00259-022-05998-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1436_CR48","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1172\/JCI98509","volume":"128","author":"IS Alam","year":"2018","unstructured":"Alam IS, Mayer AT, Sagiv-Barfi I, Wang K, Vermesh O, Czerwinski DK, et al. Imaging activated T cells predicts response to cancer vaccines. J Clin Invest. 2018;128(6):2569\u201380. https:\/\/doi.org\/10.1172\/JCI98509.","journal-title":"J Clin Invest"},{"issue":"1","key":"1436_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1158\/0008-5472.CAN-15-1707","volume":"76","author":"R Tavar\u00e9","year":"2016","unstructured":"Tavar\u00e9 R, Escuin-Ordinas H, Mok S, McCracken MN, Zettlitz KA, Salazar FB, et al. An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy. Cancer Res. 2016;76(1):73\u201382. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1707.","journal-title":"Cancer Res"},{"issue":"3","key":"1436_CR50","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1073\/pnas.1316922111","volume":"111","author":"R Tavar\u00e9","year":"2014","unstructured":"Tavar\u00e9 R, McCracken MN, Zettlitz KA, Knowles SM, Salazar FB, Olafsen T, et al. Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo. Proc Natl Acad Sci. 2014;111(3):1108\u201313. https:\/\/doi.org\/10.1073\/pnas.1316922111.","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"1436_CR51","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1634\/theoncologist.12-12-1379","volume":"12","author":"GAMS Van Dongen","year":"2007","unstructured":"Van Dongen GAMS, Visser GWM, Lub-de Hooge MN, De Vries EG, Perk LR. Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications. Oncologist. 2007;12(12):1379\u201389. https:\/\/doi.org\/10.1634\/theoncologist.12-12-1379.","journal-title":"Oncologist"},{"issue":"3","key":"1436_CR52","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.18632\/oncotarget.13910","volume":"8","author":"AJG Even","year":"2017","unstructured":"Even AJG, Hamming-Vrieze O, Van Elmpt W, Winnepenninckx VJL, Heukelom J, Tesselaar MET, et al. Quantitative assessment of Zirconium-89 labeled cetuximab using PET\/CT imaging in patients with advanced head and neck cancer: a theragnostic approach. Oncotarget. 2017;8(3):3870\u201380. https:\/\/doi.org\/10.18632\/oncotarget.13910.","journal-title":"Oncotarget"},{"issue":"1","key":"1436_CR53","doi-asserted-by":"publisher","first-page":"8791","DOI":"10.1038\/s41467-024-53197-2","volume":"15","author":"X Shen","year":"2024","unstructured":"Shen X, Zhou H, Zhou X, Liu Z, Meng X, Zhang L, et al. 68Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1\/2 clinical trial. Nat Commun. 2024;15(1):8791. https:\/\/doi.org\/10.1038\/s41467-024-53197-2.","journal-title":"Nat Commun"},{"issue":"1","key":"1436_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/cbr.2014.1709","volume":"30","author":"YS Lee","year":"2015","unstructured":"Lee YS, Kim JS, Kim JY, Kim BI, Lim SM, Kim HJ. Spatial Resolution and Image Qualities of Zr-89 on Siemens Biograph TruePoint PET\/CT. Cancer Biother Radiopharm. 2015;30(1):27\u201332. https:\/\/doi.org\/10.1089\/cbr.2014.1709.","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"1436_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.semradonc.2010.11.004","volume":"21","author":"RL Wahl","year":"2011","unstructured":"Wahl RL, Herman JM, Ford E. The Promise and Pitfalls of Positron Emission Tomography and Single-Photon Emission Computed Tomography Molecular Imaging\u2013Guided Radiation Therapy. Semin Radiat Oncol. 2011;21(2):88\u2013100. https:\/\/doi.org\/10.1016\/j.semradonc.2010.11.004.","journal-title":"Semin Radiat Oncol"},{"key":"1436_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.apradiso.2012.06.034","volume":"76","author":"A Sanchez-Crespo","year":"2013","unstructured":"Sanchez-Crespo A. Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography. Appl Radiat Isot. 2013;76:55\u201362. https:\/\/doi.org\/10.1016\/j.apradiso.2012.06.034.","journal-title":"Appl Radiat Isot"},{"key":"1436_CR57","doi-asserted-by":"publisher","first-page":"843749","DOI":"10.3389\/fmed.2022.843749","volume":"9","author":"H Feng","year":"2022","unstructured":"Feng H, Zhao Y, Yan W, Wei X, Lin J, Jiang P, et al. Identification of Signature Genes and Characterizations of Tumor Immune Microenvironment and Tumor Purity in Lung Adenocarcinoma Based on Machine Learning. Front Med. 2022;9:843749. https:\/\/doi.org\/10.3389\/fmed.2022.843749.","journal-title":"Front Med"},{"issue":"2","key":"1436_CR58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.slasd.2021.12.003","volume":"27","author":"J Ma","year":"2022","unstructured":"Ma J, Jin Y, Tang Y, Li L. DeepTI: A deep learning-based framework decoding tumor-immune interactions for precision immunotherapy in oncology. SLAS Discov. 2022;27(2):121\u20137. https:\/\/doi.org\/10.1016\/j.slasd.2021.12.003.","journal-title":"SLAS Discov"},{"key":"1436_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.semcancer.2022.11.008","volume":"87","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhao Y, Liu X, Huang J. Artificial intelligence for prediction of response to cancer immunotherapy. Semin Cancer Biol. 2022;87:137\u201347. https:\/\/doi.org\/10.1016\/j.semcancer.2022.11.008.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1436_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12859-018-2561-z","volume":"20","author":"KM Boehm","year":"2019","unstructured":"Boehm KM, Bhinder B, Raja VJ, Dephoure N, Elemento O. Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome. BMC Bioinformatics. 2019;20(1):7. https:\/\/doi.org\/10.1186\/s12859-018-2561-z.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"1436_CR61","doi-asserted-by":"publisher","first-page":"100072","DOI":"10.1016\/j.medp.2025.100072","volume":"2","author":"L Tu","year":"2025","unstructured":"Tu L, Xu A, Lou H, Huang Y, Zheng J, Chen Y, et al. Unveiling fundamental principles: visualizing T cell immunity with explainable artificial intelligence. Med Plus. 2025;2(1):100072. https:\/\/doi.org\/10.1016\/j.medp.2025.100072.","journal-title":"Med Plus"},{"issue":"2","key":"1436_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/jnen\/nlad110","volume":"83","author":"ST Alanezi","year":"2024","unstructured":"Alanezi ST, Almutairi WM, Cronin M, Gobbo O, O\u2019Mara SM, Sheppard D, et al. Whole-brain traumatic controlled cortical impact to the left frontal lobe: Magnetic resonance image-based texture analysis. J Neuropathol Exp Neurol. 2024;83(2):94\u2013106. https:\/\/doi.org\/10.1093\/jnen\/nlad110.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"1436_CR63","doi-asserted-by":"publisher","first-page":"e0215465","DOI":"10.1371\/journal.pone.0215465","volume":"14","author":"RR Beichel","year":"2019","unstructured":"Beichel RR, Ulrich EJ, Smith BJ, Bauer C, Brown B, Casavant T et al. Q <>Zhang editor 2019 FDG PET based prediction of response in head and neck cancer treatment: Assessment of new quantitative imaging features. PLoS ONE 14 4 e0215465 https:\/\/doi.org\/10.1371\/journal.pone.0215465.","journal-title":"PLoS ONE"},{"issue":"10","key":"1436_CR64","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/jop.13089","volume":"49","author":"CS Chu","year":"2020","unstructured":"Chu CS, Lee NP, Adeoye J, Thomson P, Choi S. Machine learning and treatment outcome prediction for oral cancer. J Oral Pathol Med. 2020;49(10):977\u201385. https:\/\/doi.org\/10.1111\/jop.13089.","journal-title":"J Oral Pathol Med"},{"issue":"9","key":"1436_CR65","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.crad.2021.03.017","volume":"76","author":"N Fujima","year":"2021","unstructured":"Fujima N, Andreu-Arasa VC, Meibom SK, Mercier GA, Salama AR, Truong MT, et al. Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma. Clin Radiol. 2021;76(9):711. .e1-711.e7.","journal-title":"Clin Radiol"},{"issue":"1","key":"1436_CR66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13550-020-00686-2","volume":"10","author":"RM Martens","year":"2020","unstructured":"Martens RM, Koopman T, Noij DP, Pfaehler E, \u00dcbelh\u00f6r C, Sharma S, et al. Predictive value of quantitative 18F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma. EJNMMI Res. 2020;10(1):102. https:\/\/doi.org\/10.1186\/s13550-020-00686-2.","journal-title":"EJNMMI Res"},{"issue":"10","key":"1436_CR67","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/life14101248","volume":"14","author":"A Maniaci","year":"2024","unstructured":"Maniaci A, Lavalle S, Gagliano C, Lentini M, Masiello E, Parisi F, et al. The Integration of Radiomics and Artificial Intelligence in Modern Medicine. Life. 2024;14(10):1248. https:\/\/doi.org\/10.3390\/life14101248.","journal-title":"Life"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01436-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01436-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01436-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:56:44Z","timestamp":1780023404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01436-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1436"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01436-6","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}